Risk factor
Considerable default risk
Profitability factor
Very favourable analyst view
About
IP Group Plc functions as a private equity and venture capital enterprise, allocating funds across the entire lifecycle of businesses, from initial seed and early-stage rounds to start-up, incubation, growth capital, and mature financing. A specific focus includes providing seed funding for new ventures spun out from academic institutions. The firm's investment interests are broad, encompassing sectors such as life sciences, physical sciences, energy and renewable technologies, medical devices and supplies, general healthcare, technology, cleantech, intellectual property, pharmaceuticals and biotechnology, information technology and communications, and chemicals and materials. Furthermore, it assists its university collaborators with the identification and subsequent commercialization of intellectual property. Individual investments typically range between £0.5 million and £1 million (or $0.75 million and $1.50 million), with a preference for securing equity stakes in its portfolio companies. Established in 2001, IP Group Plc is based in London, United Kingdom, and maintains a global footprint with additional offices in Wilmington, Delaware; Oxford, United Kingdom; Hong Kong S.A.R.; and Melbourne, Australia.
Company Valuation
Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV
Target Price
The average target price of IPO.L is 113 and suggests 59.9% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr